Navigation Links
Schwarz's New Epilepsy Drug Reduces Seizures

An experimental epilepsy drug, lacosamide, developed by U.S firm Schwarz has found to be potential in reducing the frequency of seizures in patients// not controlled by other drugs - the company said on Monday following the results of a phase 3 trial.

The results of the 485-patient study were presented at the North American Regional Epilepsy Congress. The results proved that epileptics treated with a 200-mg dose of the drug, lacosamide, had 14.4 percent fewer seizures than those given a placebo, while patients given a 400-mg dose had 15 percent fewer seizures than placebo-treated patients. Dizziness, headache and double vision, are considered to be the two major side effects of the drug, lacosamide - the company added.

"We are delighted that lacosamide has demonstrated efficacy in a very difficult-to-treat patient population," said Iris Loew-Friedrich, a member of Schwarz' executive board.

"This trial will be submitted to the regulatory agencies in both the European Union and the (United States) as part of the marketing authorization application for lacosamide as adjunctive therapy in adults with partial seizures," Loew-Friedrich added.

Around 2.3 million Americans suffer from epileptic seizures and about 30 percent of them require two or more drugs to control the seizures, said Mike Davis, product director for Schwarz Pharma, which is being acquired by Belgian pharmaceutical group UCB SA.

It is expected that the full results from a second Phase III trial of lacosamide will be announced early next year and the drug could be on the market within the next year or so depending on the regulatory issues. – added the report.


SRI
'"/>




Page: 1

Related medicine news :

1. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Epilepsy can be predicted
4. Epilepsy Drugs Can Enhance Risk of Birth Defects
5. Epilepsy Drug Helps Diabetic Nerve Damage
6. Epilepsy Drug May Relieve Chronic Headaches
7. More Complications Seen In Women With Epilepsy
8. Epilepsy Drugs Found To Lead To Bone Loss
9. Another Use For Epilepsy Drugs
10. Epilepsy Patients Could Benefit From Pacemakers
11. Early Surgery For Treatment Of Epilepsy Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... ... February 21, 2017 , ... ... senior director at PolicyLink, will be the keynote speaker at its second Professional ... Men of Color Framework, which develops comprehensive strategies to create and expand opportunities ...
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who ... directly related to surgery, treatment, therapy and management. Regular exercise in proper environments ... of life despite their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, the premier ... be launching its first bi-monthly issue of 2017 in February. The inaugural issue ... and One Health. , In making the announcement, American Veterinarian™ Publisher Chris ...
(Date:2/21/2017)... ... February 21, 2017 , ... Atlanta-based ... predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to date, ... by giants including Accenture, GE Ventures, and Software AG , will bring ...
(Date:2/21/2017)... ... ... A February 6 article on Healio describes a recent review ... treatments have led to significant improvements in weight loss and other health outcomes resulting ... very few problematic results relating to the treatment. Beverly Hills Physicians (BHP) says that ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... , Feb. 21, 2017 Diabetic Shoes Market: ... ... can be described as a disease, which is marked by ... production and insulin action. The disease has become a global ... death. Diabetes affects several organs of the body including eyes, ...
(Date:2/21/2017)... Feb. 21, 2017  Global health services company Cigna ... ® for breast reconstruction surgery and Dermacell ... an advanced acellular dermal matrix developed by LifeNet Health ... NVDQ ) "We are proud ... health-care payers to review the growing base of evidentiary ...
(Date:2/21/2017)... Ky. , Feb. 21, 2017 ... imaging leader, today announced a new imaging solution that connects ... Solarity® platform, one of the world,s leading scanning and ... The Solarity Connector enables hospitals to use a Lexmark ... information into the Solarity workflow, helping facilities reach ...
Breaking Medicine Technology: